arrow_back Back to App

Flu Protection: Faster Vaccines, Better Readiness, More Funding.

This act aims to strengthen the nation's defense against seasonal and pandemic influenza. It focuses on accelerating vaccine access, developing new treatments and diagnostics, and increasing public confidence in vaccinations. Citizens can expect improved access to vaccines and medications, as well as a faster response to future health threats.
Key points
Faster Vaccines: The goal is to deliver first doses of a new influenza strain vaccine within 12 weeks of its emergence.
Universal Vaccine: A universal influenza vaccine is planned for development within 10 years, potentially ending the need for annual vaccinations.
Strengthening Production: The act supports domestic production of vaccines and medical supplies to prevent future shortages.
Combating Misinformation: Actions are planned to increase vaccine confidence and combat false information.
Increased Access: Programs aim to increase access to vaccines and treatments for all populations, including high-risk groups.
Funding: Stable funding is provided for research, development, and pandemic influenza preparedness.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_9476
Sponsor: Rep. Larsen, Rick [D-WA-2]
Process start date: 2022-12-08
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Protecting America from Seasonal and Pandemic Influenza Act of 2022

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_9476.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-12-08.

What are the main provisions?

Key points include:

  • Faster Vaccines: The goal is to deliver first doses of a new influenza strain vaccine within 12 weeks of its emergence.
  • Universal Vaccine: A universal influenza vaccine is planned for development within 10 years, potentially ending the need for annual vaccinations.
  • Strengthening Production: The act supports domestic production of vaccines and medical supplies to prevent future shortages.
  • Combating Misinformation: Actions are planned to increase vaccine confidence and combat false information.
  • Increased Access: Programs aim to increase access to vaccines and treatments for all populations, including high-risk groups.
  • Funding: Stable funding is provided for research, development, and pandemic influenza preparedness.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Larsen, Rick [D-WA-2].

What is the latest detailed status?

The latest detailed status is: Introduced in House

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health Public Investments